Novavax
NVAX
#5564
Rank
A$2.13 B
Marketcap
A$12.93
Share price
2.32%
Change (1 day)
12.06%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -A$96.89 Million

According to Novavax's latest financial reports the company's current earnings are A$0.59 Billion. In 2025 the company made an earning of A$0.64 Billion, an increase over its 2024 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$96.89 Million-114.93%
2025 A$0.64 B-396.87%
2024 -A$0.22 Billion-70.39%
2023 -A$0.74 Billion-16.59%
2022 -A$0.89 Billion-62.58%
2021 -A$2.37 Billion320.54%
2020 -A$0.57 Billion234.22%
2019 -A$0.17 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.24 Billion-36.44%
2016 -A$0.38 Billion70.4%
2015 -A$0.22 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$72.33 Million81.9%
2012 -A$39.77 Million50.33%
2011 -A$26.45 Million
2009 -A$52.2 Million8.8%
2008 -A$47.98 Million18.01%
2007 -A$40.66 Million18.33%
2006 -A$34.36 Million168.31%
2005 -A$12.81 Million-62.51%
2004 -A$34.16 Million52.4%
2003 -A$22.42 Million-28.21%
2002 -A$31.23 Million
2000 -A$17.8 Million177%
1999 -A$6.43 Million-11.54%
1998 -A$7.27 Million10.64%
1997 -A$6.57 Million-9.62%
1996 -A$7.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.03 B-24,586.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.78 B-16,530.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.47 B-22,848.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.97 B-15,631.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$34.16 M-137.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion 379.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.16 B-285.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.3 Million-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.64 Billion 604.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.52 M-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA